These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 2054656

  • 1. Degeneration of the cholinergic innervation of the locus ceruleus in Alzheimer's disease.
    Strong R, Huang JS, Huang SS, Chung HD, Hale C, Burke WJ.
    Brain Res; 1991 Feb 22; 542(1):23-8. PubMed ID: 2054656
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease.
    Lehéricy S, Hirsch EC, Cervera-Piérot P, Hersh LB, Bakchine S, Piette F, Duyckaerts C, Hauw JJ, Javoy-Agid F, Agid Y.
    J Comp Neurol; 1993 Apr 01; 330(1):15-31. PubMed ID: 8468401
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Chromatographic separation of reaction products from the choline acetyltransferase and carnitine acetyltransferase assay: differential ChAT and CrAT activity in brain extracts from Alzheimer's disease versus controls.
    Bailey JA, Lahiri DK.
    J Neurochem; 2012 Aug 01; 122(4):672-80. PubMed ID: 22607230
    [Abstract] [Full Text] [Related]

  • 8. Preservation of noradrenergic neurons in the locus ceruleus that coexpress galanin mRNA in Alzheimer's disease.
    Miller MA, Kolb PE, Leverenz JB, Peskind ER, Raskind MA.
    J Neurochem; 1999 Nov 01; 73(5):2028-36. PubMed ID: 10537062
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Locus coeruleus cellular and molecular pathology during the progression of Alzheimer's disease.
    Kelly SC, He B, Perez SE, Ginsberg SD, Mufson EJ, Counts SE.
    Acta Neuropathol Commun; 2017 Jan 21; 5(1):8. PubMed ID: 28109312
    [Abstract] [Full Text] [Related]

  • 11. Alzheimer's disease: is the decrease of the cholinergic innervation of the hippocampus related to intrinsic hippocampal pathology?
    Ransmayr G, Cervera P, Hirsch EC, Berger W, Fischer W, Agid Y.
    Neuroscience; 1992 Jan 21; 47(4):843-51. PubMed ID: 1374541
    [Abstract] [Full Text] [Related]

  • 12. Superior frontal cortex cholinergic axon density in mild cognitive impairment and early Alzheimer disease.
    Ikonomovic MD, Abrahamson EE, Isanski BA, Wuu J, Mufson EJ, DeKosky ST.
    Arch Neurol; 2007 Sep 21; 64(9):1312-7. PubMed ID: 17846271
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Morphological and biochemical changes in the cholinergic and monoaminergic systems in Alzheimer-type dementia.
    Ichimiya Y, Arai H, Kosaka K, Iizuka R.
    Acta Neuropathol; 1986 Sep 21; 70(2):112-6. PubMed ID: 3739621
    [Abstract] [Full Text] [Related]

  • 16. Accumulation of 3,4-dihydroxyphenylglycolaldehyde, the neurotoxic monoamine oxidase A metabolite of norepinephrine, in locus ceruleus cell bodies in Alzheimer's disease: mechanism of neuron death.
    Burke WJ, Li SW, Schmitt CA, Xia P, Chung HD, Gillespie KN.
    Brain Res; 1999 Jan 23; 816(2):633-7. PubMed ID: 9878889
    [Abstract] [Full Text] [Related]

  • 17. [3H]vesamicol binding in human brain cholinergic deficiency disorders.
    Kish SJ, Distefano LM, Dozic S, Robitaille Y, Rajput A, Deck JH, Hornykiewicz O.
    Neurosci Lett; 1990 Sep 18; 117(3):347-52. PubMed ID: 2151294
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease.
    Gilmor ML, Erickson JD, Varoqui H, Hersh LB, Bennett DA, Cochran EJ, Mufson EJ, Levey AI.
    J Comp Neurol; 1999 Sep 06; 411(4):693-704. PubMed ID: 10421878
    [Abstract] [Full Text] [Related]

  • 20. Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer's disease. Evidence from rapid autopsy studies.
    Slotkin TA, Nemeroff CB, Bissette G, Seidler FJ.
    J Clin Invest; 1994 Aug 06; 94(2):696-702. PubMed ID: 8040324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.